- Home
- CNOB vs NNNN Comparison
CNOB vs NNNN Comparison
Compare CNOB & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNOB | NNNN |
|---|---|---|
| Founded | 1982 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1996 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CNOB | NNNN |
|---|---|---|
| Price | $27.87 | $23.82 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $30.00 | N/A |
| AVG Volume (30 Days) | ★ 276.8K | 71.3K |
| Earning Date | 01-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.63 | 0.06 |
| Revenue | ★ $341,316,000.00 | $6,920,153.00 |
| Revenue This Year | $40.81 | N/A |
| Revenue Next Year | $8.24 | N/A |
| P/E Ratio | ★ $16.89 | $464.13 |
| Revenue Growth | ★ 36.38 | N/A |
| 52 Week Low | $20.61 | $5.18 |
| 52 Week High | $29.28 | $55.65 |
Technical Indicators
Market Signals| Indicator | CNOB | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 56.84 | 43.08 |
| Support Level | $26.22 | $18.50 |
| Resistance Level | $28.45 | $34.00 |
| Average True Range (ATR) | 0.93 | 7.25 |
| MACD | -0.03 | -0.69 |
| Stochastic Oscillator | 55.07 | 17.73 |
Price Performance
Historical ComparisonAbout CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.